629
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Are USA payers moving beyond pharmaceutical budget impact models and embracing cost–effectiveness analysis?

Pages 659-660 | Published online: 09 Jan 2014

References

  • Academy of Managed Care Pharmacy. The AMCP Format for Formulary Submissions, Version 2.1 (2005).
  • Canadian Co-ordinating Office for Health Technology Assessment (CCOHTA). Guidelines for Economic Evaluation of Pharmaceuticals: Canada, 2nd Edition. CCOHTA Publications, Ontario, Canada (1997).
  • Commonwealth Department of Health and Ageing. Guidelines for the Pharmaceutical Industry on Preparation of Submissions to the Pharmaceutical Benefits Advisory Committee. Commonwealth of Australia, Publications Production Unit; Canberra, Australia (2002).
  • National Institute for Clinical Excellence. Guide to the Technology Appraisal Process. National Institute for Clinical Excellence. Report no.: N0014 (2001).
  • American Diabetes Association Consensus Panel. Guidelines for computer modeling of diabetes and its complications. Diabetes Care 27(9), 2262–2265 (2004).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.